Related Experiment Video

Updated: Aug 10, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Theoretical treatment of events between the drug-receptor association and the effect

A Gero

    Journal of Theoretical Biology
    |September 21, 1983
    PubMed

    Insights

    Pharmacological stimulus can lead to linear or nonlinear drug effects based on signal propagation. Conventional parameters are complex, and antagonism is always competitive, occurring either at the receptor or downstream.

    Area of Science:

    • Pharmacology
    • Biophysics
    • Drug Action Mechanisms

    Background:

    • Defines pharmacological stimulus as drug-induced receptor stress.
    • Explains drug effect as an observable consequence of this stress transmission.

    Purpose of the Study:

    • To elucidate the relationship between stimulus propagation and drug effect linearity.
    • To clarify the complexity of conventional pharmacological parameters.
    • To redefine the nature of drug antagonism.

    Main Methods:

    • Theoretical analysis of stimulus-response relationships.
    • Examination of drug-receptor interactions and signal transduction pathways.
    • Kinetic modeling of competitive and noncompetitive antagonism.

    Main Results:

    • Drug effects can be linear or nonlinear functions of the initial stimulus.
    • Conventional parameters (dissociation constant, efficacy, receptor concentration) are complex, involving multiple components and reactions.
    • All drug antagonism is fundamentally competitive, differing in kinetic behavior based on the site of competition.

    Conclusions:

    • The propagation pathway of receptor stress dictates the linearity of the drug effect.
    • Standard pharmacological parameters integrate numerous biological variables.
    • Antagonism kinetics depend on whether competition occurs at the receptor or downstream.

    More Related Videos

    Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission07:16

    Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

    Published on: August 16, 2018

    Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay09:03

    Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

    Published on: March 10, 2020

    Related Concept Videos

    Drug-Receptor Interactions01:29

    Drug-Receptor Interactions

    Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
    Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
    Dose-Response Relationship: Overview01:03

    Dose-Response Relationship: Overview

    Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
    Quantitative Aspects of Drug-Receptor Interaction01:30

    Quantitative Aspects of Drug-Receptor Interaction

    The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
    The Two-State Receptor Model01:29

    The Two-State Receptor Model

    The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
    The binding affinity of a drug determines its interaction with one...
    Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

    Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

    The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
    Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

    Pharmacodynamic Models: Emax Drug–Concentration Effect Model

    The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...